GUTS: Revita shows promise for durable weight maintenance post-GLP-1, with pivotal data expected soon
Revita, an endoscopic procedure for post-GLP-1 weight maintenance, is nearing pivotal data readout and regulatory filing, with strong early efficacy and safety results. The commercial strategy targets top bariatric centers, and the company is advancing a gene therapy pipeline and leveraging AI for…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.